Gene · 2074
Papers2,375
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,375
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Roles of EXO1 and RPA1 Polymorphisms in Prognosis of Lung Cancer Patients Treated with Platinum-Based Chemotherapy. | Dis Markers | 2022 | 36277983 | PubTator, text mining | PubMed |
| 8-Oxoguanine: from oxidative damage to epigenetic and epitranscriptional modification. | Exp Mol Med | 2022 | 36266447 | PubTator, text mining | PubMed |
| Clinical variant interpretation and biologically relevant reference transcripts. | NPJ Genom Med | 2022 | 36257961 | PubTator, text mining | PubMed |
| Whole blood transcriptome characterization of young female triathlon athletes following an endurance exercise: a pilot study. | Physiol Genomics | 2022 | 36250559 | PubTator, text mining | PubMed |
| Differentially expressed genes related to lymph node metastasis in advanced laryngeal squamous cell cancers. | Oncol Lett | 2022 | 36245825 | PubTator, text mining | PubMed |
| CRISPR/Cas9-A Promising Therapeutic Tool to Cure Blindness: Current Scenario and Future Prospects. | Int J Mol Sci | 2022 | 36232782 | PubTator, text mining | PubMed |
| Observing protein dynamics during DNA-lesion bypass by the replisome. | Front Mol Biosci | 2022 | 36213113 | PubTator, text mining | PubMed |
| Engrailed homeobox 1 transcriptional regulation of COL22A1 inhibits nasopharyngeal carcinoma cell senescence through the G1/S phase arrest. | J Cell Mol Med | 2022 | 36196630 | PubTator, text mining | PubMed |
| Evaluation of Genotoxicity of SU-Eohyeol Pharmacopuncture Using an In Vitro Chromosome Aberration Test in Chinese Hamster Lung Cell. | J Pharmacopuncture | 2022 | 36186089 | PubTator, text mining | PubMed |
| Pathogenic mtDNA variants, in particular single large-scale mtDNA deletions, are strongly associated with post-lingual onset sensorineural hearing loss in primary mitochondrial disease. | Mol Genet Metab | 2022 | 36182714 | PubTator, text mining | PubMed |
| Sequencing individual genomes with recurrent genomic disorder deletions: an approach to characterize genes for autosomal recessive rare disease traits. | Genome Med | 2022 | 36180924 | PubTator, text mining | PubMed |
| The Paf1 complex is required for RNA polymerase II removal in response to DNA damage. | Proc Natl Acad Sci U S A | 2022 | 36161924 | PubTator, text mining | PubMed |
| Potential gene identification and pathway crosstalk analysis of age-related macular degeneration. | Front Genet | 2022 | 36147504 | PubTator, text mining | PubMed |
| Role of Cockayne Syndrome Group B Protein in Replication Stress: Implications for Cancer Therapy. | Int J Mol Sci | 2022 | 36142121 | PubTator, text mining | PubMed |
| Prenatal Diagnosis and Outcomes in Fetuses with Hemivertebra. | Genes (Basel) | 2022 | 36140791 | PubTator, text mining | PubMed |
| CDK12 regulates co-transcriptional splicing and RNA turnover in human cells. | iScience | 2022 | 36111258 | PubTator, text mining | PubMed |
| DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination. | Front Oncol | 2022 | 36110934 | PubTator, text mining | PubMed |
| Non-canonical DNA/RNA structures associated with the pathogenesis of Fragile X-associated tremor/ataxia syndrome and Fragile X syndrome. | Front Genet | 2022 | 36110216 | PubTator, text mining | PubMed |
| The ATRX splicing variant c.21-1G>A is asymptomatic. | Hum Genome Var | 2022 | 36104326 | PubTator, text mining | PubMed |
| Genetic landscape of a large cohort of Primary Ovarian Insufficiency: New genes and pathways and implications for personalized medicine. | EBioMedicine | 2022 | 36099812 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2074/papers?page=19